US Stock MarketDetailed Quotes

SHANGHAI FOSUN PHARMACEUTICAL GROUP (SFOSF)

Watchlist
  • 2.200
  • 0.0000.00%
15min DelayClose Aug 19 14:49 ET
5.87BMarket Cap11.28P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SHANGHAI FOSUN PHARMACEUTICAL GROUP (SFOSF) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical29.27B71.28%
Medical and health services7.67B18.68%
Medical devices and medical diagnostics4.35B10.60%
Other191.7M0.47%
Adjustments and eliminations-423.58M-1.03%

By Country/Region

Currency:CNY
2024/FY
Stock NameRevenueRatio
China Mainland29.77B72.49%
Other countries or regions11.3B27.51%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +15.93%
Sample Name
Sample Code
 +10.91%
Sample Name
Sample Code
 +10.15%
4
United Sts Brent Oil Fd Lp Unit
BNO
+8.33%
5
United States Oil Fund LP
USO
+5.97%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +6.80%
Sample Name
Sample Code
 +5.98%
Sample Name
Sample Code
 +5.76%
4
KE Holdings
BEKE
+5.10%
5
H World Group
HTHT
+4.36%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On August 24 (U.S. Eastern Time), U.S. Treasury Secretary Bessent announced "unprecedented" economic actions against Iran, aiming to sever i Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -